So You Sold MAKO Surgical: Now What?

Two weeks ago, shares of MAKO Surgical skyrocketed more than 80% after the company announced it had agreed to be acquired by Stryker Corporation for $30 per share, or roughly $1.65 billion in cash.

Of course, you can't blame many shareholders for deciding to take profits following the pop.

However, if you happen to be one of those lucky investors, chances are you're now looking for another promising place to put that money to work now that MAKO's no longer an option.

In the following video, Fool contributor Steve Symington provides four stocks that former MAKO investors might consider buying with their newly won riches.

What do you think? Watch the full video below to hear Steve's four picks, then weigh in using the comments section below.

More expert advice from The Motley Fool
Still in the dark about how Obamacare might affect you and your portfolio? Don't worry -- you're not alone. To help prepare investors for the massive changes coming to the American health-care system, The Motley Fool created a special free report that makes this complex topic easily understandable. Download "Everything You Need to Know About Obamacare," and discover how the law may impact your taxes, health insurance, and investments. Click here for your free copy today.

The article So You Sold MAKO Surgical: Now What? originally appeared on Fool.com.

Fool contributor Steve Symington has no position in any stocks mentioned. The Motley Fool recommends Intuitive Surgical and iRobot. The Motley Fool owns shares of Intuitive Surgical. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.